| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |